Oct 24- Banana producer Chiquita Brands International Inc said it would start takeover talks with Brazil's Grupo Cutrale and Safra Group after its shareholders voted against a proposed merger with Irish rival Fyffes Plc. Fyffes' shares fell 5 percent to 94 euro cents in Dublin after the collapse of the deal, which would have created a company domiciled in...» Read More
LONDON, May 2- AstraZeneca's board said on Friday it had rejected an improved $106 billion takeover offer from U.S. drugmaker Pfizer, saying the bid which was announced just hours ago undervalued the firm.
*Dt Telekom rises on T-Mobile US bid speculation. The euro zone's blue-chip Euro STOXX 50 index dipped 0.3 percent to 3,188.48 points. On Friday, Deutsche Telekom rose 1.9 percent, after Reuters reported that U.S. rival Sprint had met with banks ahead of a planned bid for T-Mobile US, which is 67 percent owned by Deutsche Telekom.
LONDON, May 2- AstraZeneca's board will be reviewing a sweetened takeover offer from Pfizer but the company has no further comment at this stage, a spokeswoman for the British drugmaker said on Friday.
May 1- Pfizer Inc and AstraZeneca Plc have resumed talks about a trans-Atlantic merger of the two drug giants after Pfizer sweetened the terms of an earlier takeover offer for its British rival, the Wall Street Journal reported, citing people familiar with the matter.
VANCOUVER, May 1- Goldcorp Inc Chief Executive Chuck Jeannes said on Thursday he was disappointed the company failed in its takeover bid for Osisko Mining Corp but not overpaying for the smaller Canadian miner was the right thing to do.
Pfizer CEO Ian Read recently met with U.K.-based investors to discuss a second bid for AstraZeneca, valuing the firm at $106 billion, sources said.
May 1- Pfizer Inc may sweeten its offer for Britain's AstraZeneca Plc to more than 63 billion pounds, or $106 billion, and raise the cash portion of the deal, to kickstart negotiations, Bloomberg reported on Thursday.
PARIS, April 30- General Electric's overtures to the power business of France's former industrial beacon Alstom have shown again how the French state, for all its interventionist zeal, has limited room for manoeuvre against big business.
Alstom has until June 2 to review General Electric's $13.5 billion bid for its energy assets, reports CNBC's Mary Thompson.
Alstom is accepting GE's $13.5 billion bid for its energy assets, reports CNBC's Mary Thompson.
Jeffrey Immelt, General Electric chairman & CEO, discusses how the synergies between GE and Alstrom will likely drive earnings and increase the company's industrial mix.
CNBC's Mary Thompson reports the latest details on General Electric's attempt to acquire French company Alstom.
Nicholas Heymann, William Blair analyst, discusses General Electric's attempt to acquire Alstrom but Germany's Siemens AG is not giving up its pursuit either. Currently GE has the green light from Alstrom shareholders, says Heymann.
LONDON, April 30- British oil company Heritage Oil agreed a 924 million pound takeover offer from a fund owned by the former chief executive of Qatar's sovereign wealth fund. Its suitor, Al Mirqab Capital, is the private investment vehicle of Qatar's Sheikh Hamad Bin Jassim Bin Jabor Al Thani and his family.
*Talks not exclusive, Alstom can hold talks with Siemens. The French transport-to-turbines group is also set to receive an offer from its much larger German competitor Siemens AG, which said it had sent a letter to Alstom after its managing and supervisory boards had decided to make an offer.
CNBC's David Faber reports Siemens will make an offer for Alstonm.
*Says planned public offer in UK unit to take place in "mid-term". MADRID, April 29- Spanish bank Santander launched a buyout offer for the remaining 25 percent of its Brazilian unit, cementing its grip on one of its top profit drivers in a deal worth up to 4.7 billion euros.
Jared Bernstein, senior fellow at The Center on Budget and Policy Priorities, and Rep. Todd Young, R-Ind., discusses how America's broken corporate tax code can cause companies, like Pfizer, to incorporate outside the U.S.
Discussing Pfizer's push for a $100 billion deal for AstraZeneca, with Seamus Fernandez Leerink Partners managing director.
Pfizer is working on its next move in a potential $100 billion battle for AstraZeneca after having two bids rejected. CNBC's Meg Tirrell reports buying AstraZeneca would boost Pfizer's cancer drug pipeline.